Marker Therapeutics Receives Approval From United States Adopted Name Council and International Nonproprietary Names Expert Committee for "Neldaleucel" as Nonproprietary Name for MT-601
Marker Therapeutics 获美国采用名称委员会和国际非专利名称专家委员会的批准，将 “Neldaleucel” 作为 MT-601 的非专利名称